Back HIV Policy & Advocacy

HIV Policy & Advocacy

AIDS 2014: Romidepsin Activates Latent HIV, But Does Not Decrease Viral Reservoir

The HDAC inhibitor romidepsin was able to awaken latent HIV in resting T-cells, causing it to start producing new virus, but this was not associated with a decrease in the size of the viral reservoir in T-cells, researchers reported at the 20th International AIDS Conference this week in Melbourne. This finding suggests that kicking HIV out of hiding will not be adequate for a functional cure without strengthening immune response against the virus.

alt

Read more:

AIDS 2014: Positively Fabulous Aims to Change HIV+ Women's Lives [VIDEO]

The Positively Fabulous campaign -- participants in the Global Village at the 20th International AIDS Conference taking place this week in Melbourne, Australia --  uses art to empower women living with HIV and helps them set the agenda for responding to the epidemic.

alt

Read more:

TAG Releases 2014 HIV, Hepatitis C, and Tuberculosis Pipeline Report

The Treatment Action Group (TAG) and HIV i-Base this week released the latest edition of their annual Pipeline Report, covering new therapies and related technologies for HIV, hepatitis C, and tuberculosis (TB), in conjunction with the 20th International AIDS Conference taking place this week in Melbourne, Australia.

alt

Read more:

AIDS 2014: Law and Policy Must Be Part of the Solution for AIDS [VIDEO]

Reforming laws that criminalize and discriminate against people with HIV and key affected populations is a necessary part of the response to the epidemic, according to renowned Australian jurist the Hon. Michael Kirby, speaking at the 20th International AIDS Conference (AIDS 2014) taking place this week in Melbourne, Australia.

alt

Read more:

AIDS 2014: Researchers Discuss Progress Towards an HIV Cure [VIDEO]

Progress along the multi-pronged path towards a cure for HIV was one of the themes at the 20th International AIDS Conference (AIDS 2014), taking place this week in Melbourne. Researchers provided updates on the "Mississippi Baby," a novel assay for detecting low levels of hidden virus in the body, and using the anti-cancer drug romidepsin to reactivate latent virus.

alt

Read more: